• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Quality control of suppositories
Quality control of suppositories

... for those suppositories containing soluble active principles. This method is not suitable when the suppositories have a high powder content, which prevents the fat from sliding inside the capillary tube to give the end-point determination. When there are more numerous controls, and where studies wit ...
Procedures for Administering Injectable Drugs
Procedures for Administering Injectable Drugs

...  A patient is prescribed Co-amoxiclav IV 600mg. The stock vial that you have is 1.2g (1200mg)Bowmed brand.  The Injectable Drugs Folder says the displacement value is 0.7ml for this vial (i.e. on dissolution the 20ml expands to 20.7ml). After adding 20ml WFI you would need to withdraw 10.35ml cont ...
KEY and EXPLANATION for SET-A
KEY and EXPLANATION for SET-A

... Explanation: As the order of reaction was not mentioned it will be considered default as following First order kinetics. The general equation that suits first order kinetics is log C = log Co – kt/2.303. Where, C = amount of drug remained at time, t. Co =initial drug concentration, k = first order r ...
Charles University in Prague Faculty of Pharmacy in Hradec Králové
Charles University in Prague Faculty of Pharmacy in Hradec Králové

... stability of liposomes by the addition of specific mixtures to their surface. These socalled sterically stabilised liposomes extend circulation time in blood due to a reduced recognition rate by cells and macrophages. Most of the initial studies were made with monosialoganglioside (GM1) or phosphati ...
Oxycodone and Acetaminophen Tablets USP 5
Oxycodone and Acetaminophen Tablets USP 5

... Metabolism and Elimination A high portion of oxycodone is N-dealkylated to noroxycodone during first-pass metabolism. Oxymorphone, is formed by the O-demethylation of oxycodone. The metabolism of oxycodone to oxymorphone is catalyzed by CYP2D6. Free and conjugated noroxycodone, free and conjugated o ...
PRODUCT MONOGRAPH PrMONUROL® Fosfomycin powder, 3g
PRODUCT MONOGRAPH PrMONUROL® Fosfomycin powder, 3g

... Metoclopramide: When co‐administered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin. Other drugs that increase gastrointestinal motility may produce similar effects. Probenecid should not be co‐prescr ...
[Product Monograph Template - Standard]
[Product Monograph Template - Standard]

... BUN have been reported with the use of polymyxin B sulphate at therapeutic doses. Acute renal failure has been reported in patients on polymyxin B sulphate therapy. Nephrotoxicity is dose dependent. Baseline renal function should be assessed prior to and regularly during therapy. Since elderly patie ...
NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen
NCPDP Recommendations for Improved Prescription Container Labels for Medicines Containing Acetaminophen

... support to healthcare professionals in their attempts to educate their patients. All of these programs provide tools for the public and encourage the public to read their medicine labels and take action to make sure they do not take multiple medicines with acetaminophen simultaneously. These educati ...
A NEW GRADIENT RP- LC METHOD FOR QUANTITATIVE ANALYSIS OF... HYDROBROMIDE AND ITS RELATED SUBSTANCES IN API
A NEW GRADIENT RP- LC METHOD FOR QUANTITATIVE ANALYSIS OF... HYDROBROMIDE AND ITS RELATED SUBSTANCES IN API

... The present research describes a validated, stability- indicating and novel RP-LC method for the quantitative analysis of darifenacin hydrobromide and its four related substances in API (Active Pharmaceutical Ingredient). The chromatographic separation was achieved on a C18 stationary phase with a g ...
Xtram
Xtram

... effect on heart rate, left ventricular function, or cardiac index. Orthostatic changes in blood pressure observed. Pharmacokinetics Absorption Tramadol is rapidly and completely absorbed after oral administration of 50 mg capsules following a mean absorption delay (t0) of approximately thirty minute ...
Structural and functional validation of S
Structural and functional validation of S

... polyamine biosynthesis, PfAdoMetDC is organised into a unique bifunctional complex with ornithine decarboxylase (PfAdoMetDC/ODC) covalently linked by a hinge region, distinguishing this enzyme as unique a drug target. However, inhibitors targeting this pathway have not been successful in clinical as ...
Promus PREMIER  ™
Promus PREMIER ™

... everolimus will remain on the stent, interactions at the location of the stent itself affecting the performance of the drug cannot be ruled out. Be sure to discuss with your doctor any drugs you are taking or planning to take. ...
Antipsychotic Use in the Elderly
Antipsychotic Use in the Elderly

... Heterogeneity of outcome measures may have limited our ability to find conclusive evidence within the drug class. Overall, our network meta-analyses found that there were no significant differences in the improvement of total BPSD or BPSD subscales for psychosis, aggression and agitation across atyp ...
drug interactions with calcium channel blockers: possible
drug interactions with calcium channel blockers: possible

... Ring, 1994; Sutton et al., 1997; Zhao and Ishizaki, 1997). With the exception of nifedipine, the inhibition effects of all CCBs were increased (from 2-fold for nicardipine to ⬎10-fold for verapamil and diltiazem) when preincubated in the presence of NADPH, similar to the observation with mibefradil ...
Selegiline transdermal system in major depressive disorder
Selegiline transdermal system in major depressive disorder

... A study using data from the National Disease and Therapeutic Index, a nationally representative survey of US office-based physicians conducted by IMS HEALTH, analyzed trends in antidepressant prescribing patterns from 1987 through the third quarter of 2001 [3] . In this study, MAOIs were prescribed ...
simvastatin tablets usp - Lupin Pharmaceuticals, Inc.
simvastatin tablets usp - Lupin Pharmaceuticals, Inc.

... significantly decreased the risk of having major coronary events (CHD mortality plus hospitalverified and silent non-fatal myocardial infarction [MI]) by 34% (p<0.00001, 431 vs 622 patients with one or more events). The risk of having a hospital-verified non-fatal MI was reduced by 37%. Simvastatin ...
Synagis (palivizumab) SAMPLE CMS 1500 CLAIM FORM Box 19
Synagis (palivizumab) SAMPLE CMS 1500 CLAIM FORM Box 19

... Synagis® (palivizumab) Important Safety Information Synagis® (palivizumab) is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. Safety and efficacy were established in children with bronchopul ...
MEDICATION GUIDE ZEGERID® (ze ger id) (omeprazole / sodium
MEDICATION GUIDE ZEGERID® (ze ger id) (omeprazole / sodium

... --------------------------------------------ADVERSE REACTIONS---------------------------------------Most common adverse reactions (incidence ≥ 2%) are: Headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence (6) To report SUSPECTED ADVERSE REACTIONS, contact Valeant Pharmaceuticals Nort ...
PrVIBRAMYCIN* CAPSULES
PrVIBRAMYCIN* CAPSULES

... toxic megacolon, or perforation of colon subsequent to the administration of any antibacterial agent. CDAD has been reported to occur over 2 months after the administration of antibacterial agents. Treatment with antibacterial agents may alter the normal flora of the colon and may permit overgrowth ...
Silent Cocaine Poisoning - Asia Pacific Journal of Medical Toxicology
Silent Cocaine Poisoning - Asia Pacific Journal of Medical Toxicology

... Background: Cocaine poisoning is known for causing severe clinical effects such as tachycardia, hypertension, agitation and confusion. Absence of clinical manifestations in cocaine poisoning is unusual. Case report: A 26-year old man, known to be a cocaine addict, declared that he was forced by coca ...
Public Assessment Report Mutual Recognition Procedure
Public Assessment Report Mutual Recognition Procedure

... Warnings: As improvement may not occur during the initial weeks of therapy, patients, especially those posing a high suicidal risk, should be closely monitored during this period. Suicide/suicidal thoughts or clinical worsening. Depression is associated with an increased risk of suicidal thoughts, s ...
PA Criteria
PA Criteria

... All FDA-approved indications not otherwise excluded from Part D. Patient has selective IgA deficiency with known antibodies against IgA. All patients must have a deficiency of alpha1-proteinase inhibitor (also known as alpha1-antitrypsin) AND clinically evident emphysema. Patients initiating therapy ...
09107sgp04
09107sgp04

... the formation of these pharmacologically- induced tumours. That’s why, salmeterol is not considered to cause a significant hazard to man. Co-administration of salmeterol and fluticasone propionate(drug similar to salmeterol) were also examined. It was found that this resulted in some cardiovascular ...
Prevention Guide - Safe Handling of Hazardous Drugs
Prevention Guide - Safe Handling of Hazardous Drugs

... board of directors that includes an equal number of representatives from labour and management associations in the sector. It is primarily funded through premiums collected from all employers in the health and social service sector. ...
Colchicine for pericarditis: hype or hope? REVIEW Massimo Imazio , Antonio Brucato
Colchicine for pericarditis: hype or hope? REVIEW Massimo Imazio , Antonio Brucato

... renal disease. Colchicine and its metabolites are eliminated by the kidneys and bile. Decreased clearance through either of these two pathways increases the risk of side effects and poisoning. However, the kidneys contribute only 10– 20% of colchicine clearance, and hepatic clearance is the main det ...
< 1 ... 22 23 24 25 26 27 28 29 30 ... 584 >

Pharmacokinetics



Pharmacokinetics, sometimes abbreviated as PK (from Ancient Greek pharmakon ""drug"" and kinetikos ""moving, putting in motion""; see chemical kinetics), is a branch of pharmacology dedicated to determining the fate of substances administered externally to a living organism. The substances of interest include pharmaceutical agents, hormones, nutrients, and toxins. It attempts to discover the fate of a drug from the moment that it is administered up to the point at which it is completely eliminated from the body.Pharmacokinetics describes how the body affects a specific drug after administration through the mechanisms of absorption and distribution, as well as the chemical changes of the substance in the body (e.g. by metabolic enzymes such as cytochrome P450 or glucuronosyltransferase enzymes), and the effects and routes of excretion of the metabolites of the drug. Pharmacokinetic properties of drugs may be affected by elements such as the site of administration and the dose of administered drug. These may affect the absorption rate. Pharmacokinetics is often studied in conjunction with pharmacodynamics, the study of a drug's pharmacological effect on the body.A number of different models have been developed in order to simplify conceptualization of the many processes that take place in the interaction between an organism and a drug. One of these models, the multi-compartment model, gives the best approximation to reality; however, the complexity involved in using this type of model means that monocompartmental models and above all two compartmental models are the most-frequently used. The various compartments that the model is divided into are commonly referred to as the ADME scheme (also referred to as LADME if liberation is included as a separate step from absorption): Liberation - the process of release of a drug from the pharmaceutical formulation. See also IVIVC. Absorption - the process of a substance entering the blood circulation. Distribution - the dispersion or dissemination of substances throughout the fluids and tissues of the body. Metabolization (or biotransformation, or inactivation) – the recognition by the organism that a foreign substance is present and the irreversible transformation of parent compounds into daughter metabolites. Excretion - the removal of the substances from the body. In rare cases, some drugs irreversibly accumulate in body tissue.The two phases of metabolism and excretion can also be grouped together under the title elimination.The study of these distinct phases involves the use and manipulation of basic concepts in order to understand the process dynamics. For this reason in order to fully comprehend the kinetics of a drug it is necessary to have detailed knowledge of a number of factors such as: the properties of the substances that act as excipients, the characteristics of the appropriate biological membranes and the way that substances can cross them, or the characteristics of the enzyme reactions that inactivate the drug.All these concepts can be represented through mathematical formulas that have a corresponding graphical representation. The use of these models allows an understanding of the characteristics of a molecule, as well as how a particular drug will behave given information regarding some of its basic characteristics. Such as its acid dissociation constant (pKa), bioavailability and solubility, absorption capacity and distribution in the organism.The model outputs for a drug can be used in industry (for example, in calculating bioequivalence when designing generic drugs) or in the clinical application of pharmacokinetic concepts. Clinical pharmacokinetics provides many performance guidelines for effective and efficient use of drugs for human-health professionals and in veterinary medicine.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report